Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy-Reference-Cited by-同舟云学术

Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy

Published:2023-06-27 Issue:8 Volume:23 Page:807-815
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Yao Hao¹,Cheng Lei²,Chen Dan¹,Zhang Qian¹,Qiu Ling¹,Ren Shi-Hui¹,Dou Bai-Tao¹,Wang Huan³⁴,Huang Juan³,Fan Fang-Yi¹

Affiliation:

1. Department of Hematology and Hematopoietic Stem Cell Transplantation Center, General Hospital of the Chinese People’s Liberation Army Western Theatre, Chengdu, SiChuan, China

2. Department of Pharmacy, General Hospital of the Chinese People’s Liberation Army Western Theatre, Chengdu, SiChuan, China

3. Department of Hematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, SiChuan, China

4. University of Electronic Science and Technology of China, Chengdu, SiChuan, China

Funder

Sichuan Science and Technology Program

the general program of General Hospital of Western Theater Command

the incubation program of General Hospital of Western Theater command

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2229029

Reference93 articles.

1. Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM Patients

2. All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma

3. Current state and next-generation CAR-T cells in multiple myeloma

4. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

5. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐BCMA CAR T‐cell‐based therapy;American Journal of Hematology;2024-08-28

2. Clinical outcomes and microenvironment profiling of relapsed/refractory extramedullary disease of multiple myeloma patients with anti-BCMA CAR T cell-based therapy;2024-04-19